Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Josh RosenBengal Capital | PharmaceuticalsPharmaceuticals | Bengal Capital - GRUSF Grown Rogue's fundamental operating capabilities continue to be on display in its legacy markets of Oregon and Michigan: despite nearly- or record-low flower pricing in both markets, they managed modest year-over-year revenue growth and continued profitability. This was done... | NEUTRAL | View Pitch → | |
| Jul 31, 2026 | Substack | mindsetvalueSubstack (mindsetvalue) | PharmaceuticalsPharmaceuticals | ARA's Transformation Gains SteamGrown Rogue – GRUSF Grown Rogue is strategically expanding its cultivation operations in key U.S. states like Illinois, New Jersey, and Minnesota. The company's transition... | BULL | View Pitch → | |
| Jan 31, 2026 | Substack | Aaron M. EdelheitMindset Value Fund | PharmaceuticalsPharmaceuticals | Mindset Value Fund 2025 Q4 (GRUSF) Our research indicates that Grown Rogue may operate at more than a 50% cost advantage relative to larger U.S. cannabis operators, who mainly grow indoors. This advantage matters... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.